EO 14398: novaplex system
Active Purchase Order Awarded Last action
- Contract number
- 75D30126P21232
- Awardee
-
Seegene Usa, Inc. UEI YDDKWNE9JAY7
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $121,950
Award facts
- Opportunity
-
- 75D30126Q79195 Solicitation number
- Contract value 100% obligated
- $121,950.00 Current and potential, with all options
- Completion date 29% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Irvine, CA 92617, USA
Award details come from SAM.gov/FPDS.
About this award
The Centers for Disease Control and Prevention, Pittsburgh awarded a purchase order to Seegene USA Inc. for $121,950 on August 6, 2026, for the NOVAPLEX System under firm fixed-price pricing. Seegene USA Inc. is a foreign-owned small disadvantaged business. Performance occurs in Irvine, California, with an ultimate completion date of June 14, 2027. The order procures molecular diagnostic reagents and HPV detection kits for laboratory testing and public health screening operations.
Quick answers
Who was awarded contract 75D30126P21232?
75D30126P21232 was awarded to Seegene Usa, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on August 6, 2026.
How much is contract 75D30126P21232 worth?
The government has obligated $121,950 on 75D30126P21232.
Was contract 75D30126P21232 competed?
The extent of competition for 75D30126P21232 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award